Vivoryon Therapeutics N.V. (LON: 0R3M)
London
· Delayed Price · Currency is GBP · Price in EUR 2.000
-0.030 (-1.48%)
Jan 23, 2025, 9:22 AM BST
Vivoryon Therapeutics Market Cap
Vivoryon Therapeutics has a market cap or net worth of 44.75 million as of January 23, 2025. Its market cap has decreased by -74.40% in one year.
Market Cap
44.75M
Enterprise Value
31.84M
Revenue
-3.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.00
Market Cap Chart
Since October 27, 2014, Vivoryon Therapeutics's market cap has decreased from 106.65M to 44.75M, a decrease of -58.04%. That is a compound annual growth rate of -8.13%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.18B |
| GSK plc | 55.31B |
| Haleon | 33.62B |
| Smith & Nephew | 9.04B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 4.72B |
| HUTCHMED (China) | 1.94B |
| Oxford Nanopore Technologies | 1.44B |